HCA vs THC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HCA · HCA Healthcare$494.99 ▼ 2.46%
THC · Tenet Healthcare$283.33 ▼ 1.09%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HCA +8.3%
- THC +45.5%
Head to head
| Metric | HCA | THC |
|---|---|---|
| Price | $494.99 | $283.33 |
| Change today | ▼ 2.46% | ▼ 1.09% |
| Market cap | $103.40B | $22.55B |
| Return, 3 months | +19.6% | +9.0% |
| Return, year to date | +6.4% | +42.6% |
| Return, 1 year | +4.4% | +38.0% |
| P/E (TTM) | 16.4 | 8.3 |
| P/B | -12.8 | 4.1 |
| P/E percentile vs own 5y | 66th | 35th |
| Dividend yield | 0.62% | – |
| Revenue growth (YoY, latest qtr) | +3.6% | +18.7% |
| Net profit growth (YoY) | -2.8% | +110.5% |
| Gross margin | 42.8% | 83.3% |
| Operating margin | 15.3% | 22.5% |
| Net margin | 8.6% | 12.3% |
| Return on equity | – | 61.3% |
| Analyst target vs. price | -5.4% | +7.9% |
| Analyst buy share | 58% | 87% |
| RSI (14) | 62 | 60 |
| 30-day volatility | 38.2% | 34.3% |
| Max drawdown, 1 year | -33.6% | -34.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HCA is the largest of the group by market value.
- THC has returned the most over the past year.
- THC carries the lowest trailing P/E.
- THC is growing revenue fastest.
- THC keeps the most profit per dollar of sales.
- THC has been the calmest stock over the last 30 days.